Frankfurt - Delayed Quote EUR

Karyopharm Therapeutics Inc. (25K.F)

0.6294

-0.0008

(-0.13%)

At close: January 30 at 4:04:15 PM GMT+1

Revenue vs. Earnings

Revenue 38.78M

Earnings -32.07M

Q4'23

Q1'24

Q2'24

Q3'24

-40M

-20M

0

20M

40M

Analyst Price Targets

No Analyst Price Targets available for this ticker

Currency in USD	Current Qtr. (Dec 2024)	Next Qtr. (Mar 2025)	Current Year (2024)	Next Year (2025)
No. of Analysts	--	--	--	--
Avg. Estimate	0	0	0	0
Low Estimate	0	0	0	0
High Estimate	0	0	0	0
Year Ago EPS	--	--	--	--

Currency in USD	Current Qtr. (Dec 2024)	Next Qtr. (Mar 2025)	Current Year (2024)	Next Year (2025)
No. of Analysts	2	3	6	6
Avg. Estimate	30.29M	37.83M	150.43M	165.5M
Low Estimate	30.24M	32.69M	144.94M	139.24M
High Estimate	30.34M	45.71M	154M	195.05M
Year Ago Sales	33.75M	33.13M	146.03M	150.43M
Sales Growth (year/est)	-10.24%	14.19%	3.01%	10.02%

Currency in USD	Current Qtr. (Dec 2024)	Next Qtr. (Mar 2025)	Current Year (2024)	Next Year (2025)
Current Estimate	0	0	0	0
7 Days Ago	0	0	0	0
30 Days Ago	0	0	0	0
60 Days Ago	0	0	0	0
90 Days Ago	0	0	0	0

Currency in USD	Current Qtr. (Dec 2024)	Next Qtr. (Mar 2025)	Current Year (2024)	Next Year (2025)
Up Last 7 Days	--	--	--	--
Up Last 30 Days	--	--	--	--
Down Last 7 Days	--	--	--	--
Down Last 30 Days	--	--	--	--

	Current Qtr.	Next Qtr.	Current Year	Next Year
25K.F	--	--	--	--
S&P 500	9.01%	10.57%	14.00%	13.70%

Reiterates	HC Wainwright & Co.: Buy to Buy	1/15/2025
Maintains	Piper Sandler: Overweight to Overweight	11/6/2024
Reiterates	HC Wainwright & Co.: Buy to Buy	11/6/2024
Reiterates	HC Wainwright & Co.: Buy to Buy	11/1/2024
Reiterates	HC Wainwright & Co.: Buy to Buy	8/7/2024
Reiterates	RBC Capital: Outperform to Outperform	8/7/2024